Medibiofarma
medibiofarma.com
Actively hiring
Drug Discovery
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Medibiofarma is a Spanish biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in pharmaceutical industry.
News
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women's health
Oriva Therapeutics is launched with the support of Asabys, focused on developing innovative therapies in women's health The company incorporates two advanced assets from Oncostellae and Medibiofarma, addressing two high-unmet-need chronic conditions in wo
Read more
Report
Medibiofarma Successfully Completes Phase 2A Clinical Trial of MBF-118 for Fibrotic Crohn's Disease
Navarra, Spain - August 28, 2025 - Medibiofarma is pleased to announce the successful completion of the industrial research project titled "Investigation of Novel Agonists of the PPAR-γ Receptor for the Treatment of Crohn's Disease (PPAR-Crohn)" (Project
Read more
Report
Medibiofarma Receives 2nd Funding Award from the Crohn's & Colitis Foundation to Support Development of a New Antifibrotic Therapy
Crohn's & Colitis Foundation's IBD Ventures Awards Investment to Continue their Support for the Development of Medibiofarma's Novel First-In-Class PPARg Partial Agonist Oral Therapy (MBF-118) for Treatment of Crohn's Disease Pamplona, Spain / August 25, 2
Read more
Report
Palobiofarma and Medibiofarma open new headquarters in the AINbuilding in Cordovilla, Spain
Palobiofarma and Medibiofarma open new headquarters in the AINbuilding in Cordovilla, Spain The new facilities, of 200 square meters, consist of an office area next to a fully equipped medicinal chemistry laboratory. In this shared space, both companies w
Read more
Report
Medibiofarma S.L. announced the award of the European CommissionSeal of Excellence for their clinical asset MBF-015.
Navarra - February 2025 - Medibiofarma S.L., a clinical-stage biotechnology company developinga portfolio of new small molecule therapies announced the award of the European CommissionSeal of Excellence for their clinical asset MBF-015.The project, under
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.